Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Revised immune network concepts.

H Köhler1, T Kieber-Emmons, S Srinivasan

  • 1IDEC Pharmaceuticals Corporation, La Jolla, California 92037.

Clinical Immunology and Immunopathology
|July 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Institutional delivery rate in minority inhabited areas of China from 1996 to 2017].

Zhonghua yi xue za zhi·2019
Same author

[HIV epidemic among pregnant women in China, 2016: trend and spatial analysis].

Zhonghua yi xue za zhi·2018
Same author

[Secular trends of institutional delivery rate in China from 1996 to 2015].

Zhonghua yi xue za zhi·2017
Same author

High prevalence of occult hepatitis B among immigrant students in Canada: A case for universal immunization of young adults.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012
Same author

How good are we at advising appropriate patients with glaucoma to inform the DVLA? A closed audit loop.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2008
Same author

Sentinel node detection with radiocolloid lymphatic mapping in early invasive cervical cancer.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2005
Same journal

Mechanisms of virus replication, persistence, and regulation of immune responses.

Clinical immunology and immunopathology·2020
Same journal

Cumulative subject index for volumes 86-89

Clinical immunology and immunopathology·1998
Same journal

D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.

Clinical immunology and immunopathology·1998
Same journal

Characterization of gastric Na+/I- symporter of the rat.

Clinical immunology and immunopathology·1998
Same journal

CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.

Clinical immunology and immunopathology·1998
Same journal

Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.

Clinical immunology and immunopathology·1998
See all related articles

The idiotype network concept requires revision. A new "network antigen" model focuses on anti-idiotype affinity and regulatory networks for improved idiotype-based therapies.

Area of Science:

  • Immunology
  • Computational Biology
  • Protein Science

Background:

  • The current idiotype network concept requires updates to align with contemporary data.
  • Existing models do not fully explain T and B cell recognition of idiotopes or anti-idiotype treatment failures.

Purpose of the Study:

  • To revise the idiotype network concept for better alignment with current immunological data.
  • To introduce a new framework for understanding and utilizing idiotype-based therapies.

Main Methods:

  • Conceptual revision of idiotype network theory.
  • Introduction of the "network antigen" concept.
  • Analysis of factors controlling biological effectiveness of anti-idiotypes.

Main Results:

Related Experiment Videos

  • Proposed abandonment of Ab2 alpha, beta, gamma distinctions and the "internal image" idiotope concept.
  • Introduction of "network antigens" as potentially the entire anti-idiotype repertoire.
  • Biological effectiveness of network antigens is determined by affinity to idiotype Ig receptors and regulatory network segments.

Conclusions:

  • A revised idiotype network model, emphasizing "network antigens," is proposed.
  • Therapeutic agent screening requires evaluating anti-idiotype and idiotype antibodies.
  • Understanding network segments is crucial for rational design of idiotype-based therapies.